California lawmakers and Gov. Gavin Newsom approved new laws impacting pet owners, landlords, school bathrooms and more.

CVS Health will pay $37.76 million to settle allegations it dispensed too many insulin pens to patients, and then obtained ...

CVS Health ( CVS) has reached a settlement with the U.S. government, requiring the company to pay $37.76M to resolve claims that it overbilled government healthcare programs for insulin pens.

A record $37.8 million settlement closes a decade-long case alleging that CVS overbilled government health programs by ...

According to DataM Intelligence, the Insulin Delivery Devices Market Size reached USD 20.26 billion in 2024 and is projected to reach USD 43.11 billion by 2033, growing at a strong CAGR of 8.8% from ...

Survey shows high death rates among children with Type 1 diabetes in India due to limited insulin access and late diagnosis.

Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors.  | Dexcom said Smart Basal is the ...

Arising from: Marks JB (2008) How do detemir and glargine compare when added to oral agents in insulin-naïve patients with type 2 diabetes mellitus? Nat Clin Pract ...

Despite its small base, rapid growth in smart insulin administration, connected devices, patient-centric care, and home-based ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances. We do not ...